News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
May 8, 2025
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Please see enclosed pdf.
Attachment
08052025_trading_in_shares_GL
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
IPO
2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut
January 19, 2026
·
2 min read
·
Tristan Manalac
Venture capital
Early-Stage Biotechs Feel the Squeeze as Funding Favors Derisked Assets: JPM
January 12, 2026
·
2 min read
·
Nick Paul Taylor
IPO
UPDATE: Aktis To Become First Biotech IPO of 2026 With $318M Debut
January 8, 2026
·
2 min read
·
Annalee Armstrong
